HLA-DRA and colorectal carcinoma: Therefore, we first checked the genetic alterations of CDH1, CCL11, HLA–DRA, NOS2, NAT2, TIMP1 and TP53 in CRC patients, in TCGA cohorts via the cBioPortal online tool.